Recent Videos







banner_about_us.gif


Based near Atlanta, Georgia, EndoChoice (NYSE: GI) focuses on the manufacturing and commercialization of technologies including endoscopic imaging systems, devices and infection control products, and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

To learn more, please visit www.EndoChoice.com or www.FuseColonoscopy.org.


thumb-management.jpg

Management Team

View
Board of Directors Thumb

Board of Directors

View
thumb-events.jpg

Events

View
contact-us.jpg

Contact Us

View